Keywords: aventis, blockbusters, driving, growth, franco-german, drug, major
Aventis blockbusters driving growth
Article | 06 May 2002
Franco-German drug major Aventis has reported group net income of 424million euros ($375 million) for first-quarter 2002, an increase of 33.8%, while earnings ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscribe now
for unlimited access to all articles
Subscriptions are £60 per month, pay as you go.
Find out more details.
Already a subscriber? Click here to log in
- Elan makes "transformational" acquisitions and a divestment
- Drug prices to plunge as Indian government announces plans to regulate rates of 652 medicines
- SciClone gains China rights to Zensun's Neucardin
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- Boehringer Ingelheim transitions to propellant-free Combivent Respimat; names new BMD member
